• Home
  • About
    • About Panaxea
    • Meet our team
    • Careers
  • Services
    • Health Technology Assessment
    • Health Services & Systems Research
    • Health Innovation Assessment Consultancy
  • News & Cases
  • Publications
  • Contact
  • Privacy Statement Panaxea

Recently, a paper by Lotte Steuten was published in ‘OMICS: A Journal of Integrative Biology’. This paper is a result of a Panaxea project, to promote the need for institutional innovation to cultivate translational research.

According to Dr Steuten:

Lessons learned from this study may inform future innovation impact assessments by Technology Transfer Offices (TTOs) and translational research centers designed to accelerate knowledge-based innovation around the globe in North America, Europe, Africa, Asia and Australia

The views of Editor-in Chief of OMICS, Vural Özdemir:

We truly need new 21st century institutions, creative organizational designs, and independent think tanks that can broadly frame and measure innovation and technology transfer impacts in society. This study by Prof. Steuten makes an important contribution to translational science and the emerging field of innovation governance.

The full paper can be found here.

More information about the publication can be found on the Mary Ann Liebert website.

Panaxea b.v. supports decision making in healthcare by assessing the relative advantage of healthcare innovations. Our clients include patients, health and life science innovators and investors, health technology adopters, public and private payers, and policymakers.

Follow us on Twitter

Tweets by @PANAXEA

Useful Links

Home
About Panaxea
Services
Publications
Contact Us

Social Media

 Twitter Linkedin

Contact Information

PANAXEA b.v.
Pettelaarpark 84
5216 PP Den Bosch
The Netherlands

+31 20 7400 778
www.panaxea.eu
info@panaxea.eu

© 2019 Panaxea. All Rights Reserved.
  • Privacy Statement Panaxea
  • No translations available for this page